Markus Fahlström
Uppsala University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Markus Fahlström.
Frontiers in Neurology | 2015
Anja Smits; Maria Zetterling; Margareta Lundin; Beatrice Melin; Markus Fahlström; Anna Grabowska; Elna-Marie Larsson; Shala Ghaderi Berntsson
Diffuse low-grade gliomas (DLGG) are slow-growing brain tumors that in spite of an indolent behavior at onset show a continuous expansion over time and inevitably transform into malignant gliomas. Extensive tumor resections may be performed with preservation of neurological function due to neuroplasticity that is induced by the slow tumor growth. However, DLGG prefer to migrate along subcortical pathways, and white matter plasticity is considerably more limited than gray matter plasticity. Whether signs of functional decompensating white matter that may be found as early as at disease presentation has not been systematically studied. Here, we examined 52 patients who presented with a DLGG at the time of radiological diagnosis. We found a significant correlation between neurological impairment and eloquent cortico-subcortical tumor localization, but not between neurological function and tumor volume. These results suggest that even small tumors invading white matter pathways may lack compensatory mechanisms for functional reorganization already at disease presentation.
Acta Radiologica | 2018
Ruta Nylander; Markus Fahlström; Egill Rostrup; Joel Kullberg; Soheil Damangir; Håkan Ahlström; Lars Lind; Elna-Marie Larsson
Background Cerebral white matter hyperintensities (WMHs), lacunes, and microbleeds are seen on magnetic resonance imaging (MRI) in small vessel disease (SVD). Purpose To assess SVD on MRI and its evolution over five years in an elderly population and to investigate whether relative cerebral blood flow (rCBF) at baseline was related to the progression of white matter (WM) lesions. Material and Methods In a population-based study, 406 participants aged 75 years underwent morphological MRI of the brain and 252 of them again at age 80 years. At age 75 years, a perfusion scan was also done. WMHs were evaluated qualitatively (visual scoring) and quantitatively (CASCADE software). Lacunes and microbleeds were counted. Results A significant progression of the WMH score and WMH volume occurred over five years (P < 0.0001). New lacunes were seen in 10%. Participants with new lacunes at age 80 years showed a more pronounced increase in WMHs (P < 0.0001). Microbleeds were present in 14% at age 75 years. The visual WMH score was significantly associated with the presence of microbleeds (P < 0.0001). There was no relationship between total WM rCBF and WMH volume at age 75 years, and no significant associations between regional or total rCBF at age 75 years and changes in WMH volume over five years. The total WM and GM volume decreased significantly between the ages of 75 and 80 years (P < 0.0001). Conclusion MRI manifestations of SVD progressed over five years in an elderly population (age range = 75–80 years). rCBF was not associated with WMH volume or progression of WMH volume.
Radiology and Oncology | 2017
Anna Falk Delgado; Markus Fahlström; Markus Nilsson; Shala Ghaderi Berntsson; Maria Zetterling; Sylwia Libard; Irina Alafuzoff; Danielle van Westen; Jimmy Lätt; Anja Smits; Elna-Marie Larsson
Abstract Background Diffusion kurtosis imaging (DKI) allows for assessment of diffusion influenced by microcellular structures. We analyzed DKI in suspected low-grade gliomas prior to histopathological diagnosis. The aim was to investigate if diffusion parameters in the perilesional normal-appearing white matter (NAWM) differed from contralesional white matter, and to investigate differences between glioma malignancy grades II and III and glioma subtypes (astrocytomas and oligodendrogliomas). Patients and methods Forty-eight patients with suspected low-grade glioma were prospectively recruited to this institutional review board-approved study and investigated with preoperative DKI at 3T after written informed consent. Patients with histologically proven glioma grades II or III were further analyzed (n=35). Regions of interest (ROIs) were delineated on T2FLAIR images and co-registered to diffusion MRI parameter maps. Mean DKI data were compared between perilesional and contralesional NAWM (student’s t-test for dependent samples, Wilcoxon matched pairs test). Histogram DKI data were compared between glioma types and glioma grades (multiple comparisons of mean ranks for all groups). The discriminating potential for DKI in assessing glioma type and grade was assessed with receiver operating characteristics (ROC) curves. Results There were significant differences in all mean DKI variables between perilesional and contralesional NAWM (p=<0.000), except for axial kurtosis (p=0.099). Forty-four histogram variables differed significantly between glioma grades II (n=23) and III (n=12) (p=0.003−0.048) and 10 variables differed significantly between ACs (n=18) and ODs (n=17) (p=0.011−0.050). ROC curves of the best discriminating variables had an area under the curve (AUC) of 0.657−0.815. Conclusions Mean DKI variables in perilesional NAWM differ significantly from contralesional NAWM, suggesting altered microstructure by tumor infiltration not depicted on morphological MRI. Histogram analysis of DKI data identifies differences between glioma grades and subtypes.
Neuromodulation | 2016
Elena Jiltsova; Timo Möttönen; Markus Fahlström; Joonas Haapasalo; Timo Tähtinen; Jukka Peltola; Juha Öhman; Elna-Marie Larsson; Tommi Kiekara; Kai Lehtimäki
Deep brain stimulation (DBS) of the anterior nucleus of thalamus (ANT) is an evolving treatment option in refractory focal epilepsy. Due to poor visualization of ANT in traditional MRI sequences used for movement disorder surgery, targeting of ANT is mainly based on stereotactic atlas information. Sophisticated 3T MRI methods enable visualization of ANT, but 1.5T MRI is still preferred or more readily available in a large number of centers performing DBS.
Radiology and Oncology | 2018
Markus Fahlström; Erik Blomquist; Tufve Nyholm; Elna-Marie Larsson
Abstract Background The aim of this study was assess acute and early delayed radiation-induced changes in normal-appearing brain tissue perfusion as measured with perfusion magnetic resonance imaging (MRI) and the dependence of these changes on the fractionated radiotherapy (FRT) dose level. Patients and methods Seventeen patients with glioma WHO grade III-IV treated with FRT were included in this prospective study, seven were excluded because of inconsistent FRT protocol or missing examinations. Dynamic susceptibility contrast MRI and contrast-enhanced 3D-T1-weighted (3D-T1w) images were acquired prior to and in average (standard deviation): 3.1 (3.3), 34.4 (9.5) and 103.3 (12.9) days after FRT. Pre-FRT 3D-T1w images were segmented into white- and grey matter. Cerebral blood volume (CBV) and cerebral blood flow (CBF) maps were calculated and co-registered patient-wise to pre-FRT 3D-T1w images. Seven radiation dose regions were created for each tissue type: 0–5 Gy, 5–10 Gy, 10–20 Gy, 20–30 Gy, 30–40 Gy, 40–50 Gy and 50–60 Gy. Mean CBV and CBF were calculated in each dose region and normalised (nCBV and nCBF) to the mean CBV and CBF in 0-5 Gy white- and grey matter reference regions, respectively. Results Regional and global nCBV and nCBF in white- and grey matter decreased after FRT, followed by a tendency to recover. The response of nCBV and nCBF was dose-dependent in white matter but not in grey matter. Conclusions Our data suggest that radiation-induced perfusion changes occur in normal-appearing brain tissue after FRT. This can cause an overestimation of relative tumour perfusion using dynamic susceptibility contrast MRI, and can thus confound tumour treatment evaluation.
Neuroradiology | 2014
Anna Falk; Markus Fahlström; Egill Rostrup; Shala Ghaderi Berntsson; Maria Zetterling; Arvid Morell; Henrik B.W. Larsson; Anja Smits; Elna-Marie Larsson
Archive | 2017
Johanna Mårtensson; Jimmy Lätt; Danielle van Westen; Berry Kremer; Markus Fahlström; Katarina Laurell; Johan Virhammar; Elna-Marie Larsson
Läkartidningen | 2017
Markus Fahlström; Irfan Subasic; Priit Teder; Karin Åberg; Elna-Marie Larsson; Carina Blomström-Lundqvist
XXII Congress of the European Society for Stereotactic and Functional Neurosurgery, Madrid, Spain, September 28 – October 1, 2016 | 2016
Ruben Cubo; Elena Jiltsova; Markus Fahlström; Helena Andersson; Alexander Medvedev
Archive | 2015
Anna Falk Delgado; Markus Fahlström; Nilsson Markus; Shala Ghaderi Berntsson; Maria Zetterling; Irina Alafuzoff; Danielle van Westen; Jimmy Lätt; Anja Smits; Elna-Marie Larsson